ZURICH (Thomson Financial) - Roche Holdings AG and Quidel Corporation said
they have started a pilot project in the US to develop a comprehensive approach
to managing influenza.
A test called QuickVue Influenza A+B and the Tamiflu drug will be used in
the programme, which is scheduled to begin in December.
The latest cooperation between the Swiss pharma giant and the US-based
Quidel adds to a collaboration that is already underway in Germany.
huimin.neo@thomson.com
hmn/jfr
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|